SearchDictionaryMobileLogin

Dermatomyositis (Dermatopolymyositis)

1522  relevant articles (109 outcomes, 125 trials/studies) found for this Disease

Description: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)

Also Known As:
Dermatopolymyositis; Polymyositis Dermatomyositis; Dermatomyositis, Adult Type; Dermatomyositis, Childhood Type; Adult Type Dermatomyositides; Adult Type Dermatomyositis; Childhood Type Dermatomyositides; Childhood Type Dermatomyositis; Dermatomyositides; Dermatomyositides, Adult Type; Dermatomyositides, Childhood Type; Dermatopolymyositides; Polymyositis-Dermatomyositides; Polymyositis-Dermatomyositis

Relationship Network

Disease Context: Research Results

Related Diseases

1. Polymyositis
2. Syndrome
3. Myositis (Idiopathic Inflammatory Myopathies)
4. Systemic Lupus Erythematosus (Libman-Sacks Disease)
5. Vasculitis (Vasculitides)

Experts

1. Callen, Jeffrey P: 6 articles (01/2006 - 09/2002)
2. Pachman, Lauren M: 5 articles (02/2008 - 11/2002)
3. Lundberg, Ingrid E: 4 articles (10/2008 - 04/2002)
4. Tamaki, Kunihiko: 4 articles (08/2007 - 07/2002)
5. Ihn, Hironobu: 4 articles (08/2007 - 07/2002)
6. Kuwana, Masataka: 4 articles (05/2007 - 05/2005)
7. Werth, Victoria P: 4 articles (01/2006 - 09/2002)
8. Wedderburn, L R: 3 articles (07/2008 - 04/2004)
9. Pilkington, C A: 3 articles (07/2008 - 04/2004)
10. Makino, Shigeki: 3 articles (02/2008 - 06/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Dermatomyositis:
1. Intravenous Immunoglobulins (IVIG)FDA Link
2. Adrenal Cortex Hormones (Corticosteroids)IBA
3. Cyclosporine (Ciclosporin)FDA LinkGeneric
4. Immunoglobulins (Immunoglobulin)IBA
5. Methotrexate (Mexate)FDA LinkGeneric
6. Cyclophosphamide (Cytoxan)FDA LinkGeneric
7. Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
8. rituximab (Mabthera)FDA Link
9. Prednisolone (Predate)FDA LinkGeneric
10. Azathioprine (Imuran)FDA LinkGeneric

Therapies and Procedures

1. Aftercare (After-Treatment)
2. Transplants (Transplant)
07/29/1978 - "II) concentrations in 26 patients with lupus erythematosus, 4 with dermatomyositis, 2 with autoimmune haemolytic anaemia, and in 40 immunosuppressed renal-transplant patients showed that T.C. "
06/01/2008 - "Forty-three patients (4-18 years) with renal glomerular diseases, dermatomyositis, inflammatory bowel disease, juvenile rheumatoid arthritis, post-solid organ transplant, and Duchenne muscular dystrophy were studied. "
01/01/2008 - "Besides the classical inflammatory myopathies (IM), dermatomyositis (DM), polymyositis, and inclusion body myositis, the much larger spectrum of IM includes focal and nodular myositis, granulomatous myositis, macrophagic myofasciitis, graft vs. host myositis, eosinophilic myositis, and other immune-associated conditions, some of them only recently described. "
12/01/2003 - "As a relatively well-tolerated immunosuppressive used in organ transplant recipients, MMF has recently been reported to show promise for several dermatologic conditions, including psoriasis, pemphigus vulgaris, pyoderma gangrenosum, bullous lichen planus, and even connective tissue diseases such as lupus erythematosus and dermatomyositis. "
12/01/2005 - "Since the early 1980s, the therapeutic efficacy of IVIg has been established in idiopathic thrombocytopenic purpura, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, dermatomyositis and Kawasaki syndrome, and the prevention of graft versus host disease in recipients of allogeneic bone marrow transplants. "
Order ALL the reference details at left...
3. Drug Therapy (Chemotherapy)
4. Plasmapheresis
5. Immunotherapy

Best Treatments:
Research Summary Report
on Dermatomyositis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 109 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>